Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor Model-Reference-Cited by-同舟云学术

Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor Model

Published:2020-05-15 Issue:12 Volume:61 Page:1800-1805
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Cullinane Carleen,Jeffery Charmaine M.,Roselt Peter D.,van Dam Ellen M.,Jackson Susan,Kuan Kevin,Jackson Price,Binns David,van Zuylekom Jessica,Harris Matthew J.,Hicks Rodney J.,Donnelly Paul S.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference40 articles.

1. Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors

2. 68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis

3. Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy

4. Favourable outcomes of 177Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours

5. Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN);Kong;Eur J Nucl Med Mol Imaging.,2019

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide PET Imaging: A Review of Recent Developments and a Look at the Future of Radiometal-Labeled Peptides in Medicine;Chemical & Biomedical Imaging;2024-08-22

2. Copper and Copper Complexes in Tumor Therapy;ChemMedChem;2024-03-22

3. Efficacy of [⁶⁷Cu]Cu-EB-TATE Theranostic Against Somatostatin Receptor Subtype-2–Positive Neuroendocrine Tumors;Journal of Nuclear Medicine;2024-03-14

4. Radiolabeling Diaminosarcophagine with Cyclotron-Produced Cobalt-55 and [⁵⁵Co]Co-NT-Sarcage as a Proof of Concept in a Murine Xenograft Model;Bioconjugate Chemistry;2024-02-27

5. Effectiveness of [67Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-02-20